|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
6 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Accrual of in-kind interest on notes payable to related parties | |||||
| Depreciation and amortization expense | |||||
| Stock-based compensation expense | |||||
| Loss on debt extinguishment | |||||
| Amortization of debt issuance costs | |||||
| Provision for doubtful accounts | |||||
| Inventory obsolescence write down | |||||
| Change in deferred income taxes | |||||
| Loss on disposal of property, plant and equipment and badges | |||||
| (Gain) loss on foreign currency transactions | |||||
| Increase in fair values of warrant liabilities | |||||
| Amortization of deferred revenue step-down | |||||
| Amortization of inventory step-up | |||||
| Goodwill impairment | |||||
| (Gain) loss on disposal of business | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Costs in excess of billings on uncompleted contracts | |||||
| Inventories | |||||
| Deferred cost of revenue | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred contract revenue | |||||
| Other assets | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Acquisition of Mirion, net of cash and cash equivalents acquired | |||||
| Acquisitions of businesses, net of cash and cash equivalents acquired | |||||
| Proceeds from disposal of property, plant, and equipment and badges | |||||
| Purchases of property, plant, and equipment and badges | |||||
| Proceeds from net investment hedge derivative contracts | |||||
| Proceeds from business disposal | |||||
| Other investing | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Issuances of common stock | |||||
| Common stock issuance costs | |||||
| Stock repurchased to satisfy tax withholding for vesting restricted stock units | |||||
| Purchases of stock for treasury | |||||
| Transaction fees reimbursed by Sellers | |||||
| Payment of deferred underwriting costs | |||||
| Borrowings from third-parties, net of discount and issuance costs | |||||
| Proceeds from issuance of convertible senior notes, net of bank costs | |||||
| Third-party issuance costs for convertible senior notes | |||||
| Purchase of capped calls related to convertible senior notes | |||||
| Term loan principal repayments | |||||
| Financing costs | |||||
| Borrowings from notes payable – related parties | |||||
| Payment on revolving term loan | |||||
| Proceeds from cash flow hedge derivative contracts | |||||
| Other financing | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
Loading...